Radiofrequency ablation devices market seen reaching $9.55 billion by 2030

The Business Research Company forecasts the global radiofrequency ablation devices market will rise from $5.91 billion in 2026 to $9.55 billion by 2030, driven by cancer, chronic pain and broader use of minimally invasive procedures. North America led the market in 2025, while Asia-Pacific is expected to grow fastest.

Why it matters: - Radiofrequency ablation devices are used to destroy abnormal tissue with heat and to manage chronic pain, so demand tracks broader trends in cancer care, pain treatment and minimally invasive procedures. - The projected rise to $9.55 billion by 2030 signals continued investment in image-guided oncology, cardiac care and outpatient treatment settings.

What happened: - The Business Research Company released its Radiofrequency Ablation Devices Market Report 2026, covering market size, trends and global forecasts for 2026-2035. - The market is expected to grow from $5.25 billion in 2025 to $5.91 billion in 2026. - The company projects the market will reach $9.55 billion by 2030. - The forecast implies a 12.5% CAGR from 2025 to 2026 and a 12.8% CAGR through 2030. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region over the coming years.

The details: - The report links near-term growth to rising cancer rates, chronic pain disorders, wider access to interventional treatments, broader acceptance of thermal ablation therapies, increased adoption of RF generator platforms and more outpatient procedures. - Longer-term growth is tied to higher demand for image-guided oncology therapies, greater use of RF ablation in cardiac care, more ambulatory surgical procedures, stronger focus on targeted pain management and investment in advanced ablation technologies. - Key trends include minimally invasive ablation techniques, disposable ablation catheters, imaging-guided ablation systems, expanding pain management uses and more precise tissue targeting. - Chronic diseases are a major driver because they can require ongoing treatment and often cause persistent pain or tumor growth. - The World Health Organization said in February 2024 that new cancer cases could exceed 35 million by 2050, up 77% from an estimated 20 million cases in 2022. - The report defines radiofrequency ablation devices as tools that use medium-frequency alternating currents to generate heat and destroy abnormal tissue. - The devices are used in cancer treatment and to disrupt pain signals in chronic pain care. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The 2026 report package includes market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel dashboards, market hotspots infographics, key technologies and future trends, plus updated graphics and tables. - The company also offered a free sample report and a full report through links in the release, along with contact details for sales and media outreach. - Free sample report - Full market report - Company LinkedIn page

Between the lines: - The forecast suggests the market is shifting from a niche procedural category toward a broader platform for oncology, pain management and cardiac interventions. - Faster growth in Asia-Pacific points to rising procedure volumes and expanding adoption of advanced treatment technologies outside North America. - The emphasis on disposable catheters, imaging integration and outpatient care suggests providers are prioritizing efficiency, precision and shorter recovery times.

What's next: - The market is expected to keep expanding through 2030 if cancer incidence, chronic disease prevalence and outpatient procedure volumes continue to rise. - Adoption should remain strongest where hospitals and ambulatory centers invest in image-guided systems and advanced RF platforms. - The regional shift toward Asia-Pacific could reshape where manufacturers focus sales, distribution and product development.